Category Archives: Pr Newswire

Thomas Pigeon Appointed as CMO of Eterna Health, Enhancing the Brand’s Reach in Regenerative Medicine MISSISSAUGA , Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) — Dr. Adeel Khan, CEO and Founder of Eterna Health today announces the appointment of Thomas Pigeon as Chief Marketing Officer “Our growth curve has been rapid and exciting. As we evolve […]

– Recent Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrated Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints – – Strengthened Balance Sheet with $374 Million Public Offering Extending Projected Cash Runway At Least Into the Second Half of 2026 – WALTHAM, Mass., […]

MARKHAM, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights Adjusted EBITDA(1) excluding out-of-period items improved by $19.7 million to $34.5 million, largely driven by rate increases in long-term care (“LTC”) and […]

NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its second quarter 2024 financial results and provided a business update. “Our work in hypertension and coronary artery disease aligns […]

FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare […]

Adalimumab-aaty was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available among key distributors across the U.S. on July 2, 2023 Adalimumab-aaty’s inclusion creates greater accessibility to treatments for Americans with inflammatory conditions JERSEY CITY, N.J., Aug. 13, 2024 /PRNewswire/ — Celltrion USA, Inc., (Celltrion USA) today announced […]

Toss Securities logs exceptional financial performance, achieving full-year target in just six months Strong performance in U.S. securities trading was instrumental in driving growth Building on quarterly profit in Q1, Toss Securities’ strong Q2 results highlight consistent profitability SEOUL, South Korea, Aug. 13, 2024 /PRNewswire/ — Toss Securities has reported a strong performance in the […]

LETHAM, Scotland, Aug. 13, 2024 /PRNewswire/ — MDJM LTD (Nasdaq: MDJH) (the “Company” or “MDJM”), an integrated global culture-driven asset management company, announced today the appointment of Dr. Pei-Kai Cheng to the Expert Committee of its wholly owned subsidiary, MD Local Global Limited, a United Kingdom Company. Dr. Cheng’s involvement marks a significant enhancement to […]

OXFORD, England, Aug. 13, 2024 /PRNewswire/ — Unipart, the supply chain solutions and performance improvement technologies partner, has announced the acquisition of the former Schaeffler Rail Bearing reconditioning business in Auburn, New South Wales. Mark Carling, Unipart Rail Australia & Asia Pacific Managing Director The acquisition was completed on 12 August 2024, transferring the business […]

DUBAI, UAE, Aug. 13, 2024 /PRNewswire/ — Yalla Group Limited (“Yalla” or the “Company”) (NYSE: YALA), the largest Middle East and North Africa (MENA)-based online social networking and gaming company, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial and Operating Highlights Revenues were US$81.2 million in the second […]